EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities

Adriana Ribeiro iD, Daniele Oliveira, Helena Cabral-Marques

Molecules · 21.01.2025 · 30 (3) · 457

DOI: 10.3390/molecules30030457 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 21.01.2025. Verfasst von Adriana Ribeiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal. Hauptthemen laut MEDLINE: Curcumin, Eye Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT—Foundation for Science and Technology, I.P., through National Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular diseases affecting the anterior and posterior segments of the eye are major causes of global vision impairment. Curcumin, a natural polyphenol, exhibits anti-inflammatory, antioxidant, antibacterial, and neuroprotective properties, making it a promising candidate for ocular therapy. However, its clinical use is hindered by low aqueous solubility, poor bioavailability, and rapid systemic elimination. This review comprehensively highlights advances in curcumin delivery systems aimed at overcoming these challenges. Emerging platforms, including proniosomal gels, transferosomes, and cyclodextrin complexes, have improved solubility, permeability, and ocular retention. Nanoparticle-based carriers, such as hybrid hydrogels and biodegradable nanoparticles, enable sustained release and targeted delivery, supporting treatments for posterior segment diseases like diabetic retinopathy and age-related macular degeneration. For anterior segment conditions, including keratitis and dry eye syndrome, cyclodextrin-based complexes and mucoadhesive systems enhance corneal permeability and drug retention. Mechanistically, curcumin modulates key pathways, such as NF-κB and TLR4, reducing oxidative stress, angiogenesis, and apoptosis. Emerging strategies like photodynamic therapy and neuroprotective approaches broaden their application to eyelid conditions and neuroinflammatory ocular diseases. These advancements address curcumin’s pharmacokinetic limitations, supporting its clinical translation into ophthalmic therapies. This work underscores curcumin’s potential in ocular disease management and advocates clinical trials to validate its safety, efficacy, and therapeutic relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminEye DiseasesHumansAnimalsNanoparticlesDrug Delivery SystemsOphthalmology

Stichwörter der Autor:innen

anti-inflammatorybioavailabilitycurcumincyclodextrin complexesdrug delivery systemsnanoparticlesneuroprotective propertiesocular diseasesophthalmic therapiesposterior segment diseases

Substanzen

Curcumin

Autor:innen und Institutionen

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
  • Ophthalmologist, Centro Hospitalar de Setúbal and Hospital da Luz Setúbal, 2900-722 Setúbal, Portugal.

ORCID-Profile: Adriana Ribeiro

Förderung

  • FCT—Foundation for Science and Technology, I.P., through National Funds

Zitieren

APA

Ribeiro, A., Oliveira, D., & Cabral-Marques, H. (2025). Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities. Molecules, 30(3), 457. https://doi.org/10.3390/molecules30030457

Vancouver

Ribeiro A, Oliveira D, Cabral-Marques H. Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities. Molecules. 2025;30(3):457. doi:10.3390/molecules30030457

BibTeX
@article{Ribeiro2025,
  author = {Ribeiro, Adriana and Oliveira, Daniele and Cabral-Marques, Helena},
  title = {Curcumin in Ophthalmology: Mechanisms, Challenges, and Emerging Opportunities},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {3},
  pages = {457},
  doi = {10.3390/molecules30030457}
}
Kostenlos starten →